HHS Advisory Council Meeting
Assessment of the Healthcare System Capacity to Support Blood and Marrow Stem Cell Transplantation
Jeffrey Chell, M.D.
Chief Executive Officer National Marrow Donor Program® September 2009 Entrusted to operate the CW Bill Young Cell Transplantation Program
Goal for this Presentation
Acquaint you with a Summit planned by the NMDP and ASBMT
– Assess the capacity of the US Healthcare System to support a significant increase in unrelated Allogeneic transplants 10,000 Transplants by 2015 – Identify most likely barriers in the system that would inhibit growth – Recommend solutions
2
Overarching Goal
• 10,000 Transplants by 2015
– Why 10,000? • Studies performed separately by NMDP and CIBMTR identified the need in the U.S. to be in this range based on current indications aged 0 to 60. • Causes an organization like NMDP to think outside of our current activities and business model to influence others to prepare for supporting this degree of growth
Slide 3
Overarching Goal
• 10,000 Transplants by 2015
– Why 10,000? • Effective Communication Tool to Key Stakeholders who would have to have advance notice to prepare for a 2 to 3 fold increase in their activity. • Effective Tool within NMDP to focus on high priority activities to support the achievement of the goal.
Slide 4
Overarching Goal
• 10,000 Transplants by 2015
– Why 2015? • Gives a sense of urgency to the goal. The need is 10,000 per year today. If you know that, then you don’t want to waste anytime getting there! • Increases realization that key initiatives and investments need to start today to achieve the goal.
Slide 5
Impact of Overarching Goal at NMDP
• Significant increase in the number and diversity of Cord Blood Units • Significant increase in adult donor recruitment
– 350k in 2006 to 500k in 2010
• Increase in International Partnerships
– NetCord, several countries
• Improved matching algorithm • Increased Patient Advocacy and Assistance • New project in re-engineering the donor management process
– Phoenix Initiative
Slide 6
10,000 Transplants by 2015
• Major factors threatening this target are – Lack of suitable donors for all patients – Non-HLA barriers to access. • Insurance, timely referral, attitudes – Mortality and morbidity • Research, which is translated into changes in clinical practice, is essential for improving access, survival and quality of life following transplantation
Slide 7
“System” Issues
• Money
– Financing of transplant - Insurance – Capital investment in space and technology
• People
– Transplant physicians – Nurses – Allied Health personnel
• Attitude
– Transplant works – It’s a cost effective health care strategy
Slide 8
HSC Summit
• Bringing together of ASBMT, NMDP and Key Stakeholders to identify healthcare system capacity issues and formulate “upstream” solutions • Examples of organization that have members that would be part of the response to growth include: UHC, AAMC, ONS, ASCO. AMA, AHA, etc.
Slide 9
HSC Summit
• Examples
– How and when does one influence someone in training to consider transplant as a career? – What would cause a healthcare center to invest in transplant services? • Combination of mission, profit, prestige • Timing of investment to increase capacity and ROI
Slide 10
HSC Summit - Process
• Core Committee develops case statement, plans working groups, selects working group chairs • Core Committee plus Working Group Chairs charter each working group, select working group members • Broad group of individuals and organizations will be invited to the summit to hear the deliberations of the Working Groups and give comments
Slide 11
HSC Summit - Process
• A “white paper” will be generated from the proceedings and distributed to participants for comment. • Final product should be suitable for publication. • Ultimate goal will be that invited organizations will transform recommendations from the summit into priority initiatives for the organization and its members.
Slide 12
HSC Summit
• Thank you • Questions?
Slide 13
Be The Match Many coming together for the benefit of one
Health care Professionals Donors
PATIENT
Contributors
Volunteers
14